Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
However, it carries a BBB F rating due to unresolved customer complaints, Trustpilot flagged its review page for suspected inauthentic reviews, and Eli Lilly filed a lawsuit against the company in April 2025
A schema with the study design is depicted in Supplementary Fig
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension
Its also seen after bariatric surgery or extreme dieting
A medical provider will typically evaluate: Starting weight and BMI Individuals with higher BMI levels may benefit from treatments that support greater appetite regulation
US$ 28.22
US$ 20.46
US$ 21.31
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
